Novofem (Estradiol | Norethisterone Acetate, Estradiol)

Estradiol, the active ingredient in Novofem, is a hormonal estrogen presented as a oral tablet for systemic use. It treats menopausal symptoms and hormone replacement therapy needs in women. Novofem combines estradiol with norethisterone acetate, a progestogenic agent, to provide balanced hormone therapy.

GNH USA supplies Novofem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Novofem is used in hormone replacement therapy, acting on estrogen‑dependent pathways to alleviate symptoms associated with low endogenous hormone levels. - Menopausal vasomotor symptoms: Reduces hot flashes and night sweats. - Osteoporosis prevention: Helps maintain bone mineral density. - Hypo‑estrogenic states due to ovarian failure: Restores estrogen activity. - Endometrial protection in combined therapy: Prevents estrogen‑induced endometrial hyperplasia. - Contraceptive management: Provides progestogenic support in combined regimens.

Novofem may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: Mild stomach upset often reported. - Breast tenderness: Sensitivity or swelling of breast tissue. - Headache: Transient headache episodes. - Mood changes: Fluctuations in mood or irritability. - Vaginal spotting: Light bleeding between periods. - Weight gain: Slight increase in body weight.

Serious or Rare Side Effects: - Thromboembolic events: Deep vein thrombosis or pulmonary embolism. - Stroke: Cerebrovascular accident risk, especially in smokers. - Hepatic dysfunction: Elevated liver enzymes or jaundice. - Gallbladder disease: Gallstones or cholecystitis. - Breast cancer: Potential increased risk with long‑term use. - Endometrial cancer: Risk if estrogen is not adequately opposed.

Before prescribing Novofem, clinicians should evaluate patient history and risk factors. - Cardiovascular assessment: Review history of clotting, stroke, or heart disease. - Cancer screening: Ensure no active breast or endometrial cancer. - Smoking status: Advise cessation, especially in women over 35. - Liver function: Monitor hepatic enzymes in patients with liver disease. - Blood pressure: Check for hypertension before initiating therapy. - Store at ambient temperature: Keep below 25 °C, in original packaging, protected from moisture.

Novofem can interact with several medication classes, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants: May increase risk of bleeding. - Certain antiepileptics (e.g., carbamazepine, phenytoin): Reduce hormonal levels. - Rifampicin: Lowers estradiol concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensives: May affect blood pressure control. - SSRIs/SNRIs: Can increase risk of serotonin syndrome when combined with hormonal therapy. - Thyroid hormones: May require dose adjustment of levothyroxine.